VIDAS HBs Ag Ultra Confirmation - Hepatitis B virus surface antigen IVD, kit, enzyme immunoassay (EIA)
Pajjiż: Awstralja
Lingwa: Ingliż
Sors: Department of Health (Therapeutic Goods Administration)
Rapport ta 'Valutazzjoni Pubblika
(PAR)
22-11-2017
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Disponibbli minn:
Biomerieux Australia Pty Ltd
Klassi:
Class 4
Manifatturat minn:
Biomerieux SA 376 Chemin de l'Orme, Marcy, L Etoile, 69280 France
Żona terapewtika:
48319 - Hepatitis B virus surface antigen IVD, kit, enzyme immunoassay (EIA)
Indikazzjonijiet terapewtiċi:
Supplementary VIDAS HBs Ag Ultra kit for confirmation of the presence of hepatitis B surface antigen in human serum or plasma found to be repeatedly positive with the VIDAS HBs Ag Ultra kit (ref. 30315). Supplementary VIDAS HBs Ag Ultra kit for confirmation of the presence of hepatitis B surface antigen in human serum or plasma found to be repeatedly positive with the VIDAS HBs Ag Ultra kit (ref. 30315).
L-istatus ta 'awtorizzazzjoni:
A
Data ta 'l-awtorizzazzjoni:
2014-05-23
